Abbott Labs (ABT) PT Raised to $141 at Barclays
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $111.25 -0.02%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Abbott Labs (NYSE: ABT) to $141.00 (from $133.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Deutsche Boerse AG (DB1:GR) (DBOEY) PT Raised to EUR252 at RBC Capital
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
